PMC:7696151 / 85169-85497 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2534","span":{"begin":12,"end":20},"obj":"Species"},{"id":"2547","span":{"begin":121,"end":133},"obj":"Chemical"},{"id":"2548","span":{"begin":155,"end":158},"obj":"Chemical"},{"id":"2549","span":{"begin":265,"end":268},"obj":"Chemical"},{"id":"2567","span":{"begin":32,"end":38},"obj":"Disease"},{"id":"2568","span":{"begin":53,"end":61},"obj":"Disease"},{"id":"2569","span":{"begin":207,"end":212},"obj":"Disease"},{"id":"2570","span":{"begin":309,"end":317},"obj":"Disease"}],"attributes":[{"id":"A2534","pred":"tao:has_database_id","subj":"2534","obj":"Tax:9606"},{"id":"A2547","pred":"tao:has_database_id","subj":"2547","obj":"MESH:C401859"},{"id":"A2548","pred":"tao:has_database_id","subj":"2548","obj":"MESH:D006886"},{"id":"A2549","pred":"tao:has_database_id","subj":"2549","obj":"MESH:D006886"},{"id":"A2567","pred":"tao:has_database_id","subj":"2567","obj":"MESH:D009369"},{"id":"A2568","pred":"tao:has_database_id","subj":"2568","obj":"MESH:D008545"},{"id":"A2569","pred":"tao:has_database_id","subj":"2569","obj":"MESH:D009369"},{"id":"A2570","pred":"tao:has_database_id","subj":"2570","obj":"MESH:D064420"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"study on 27 patients with solid tumors and 12 with a melanoma diagnosis. In both cases, the standard intravenous dose of temsirolimus with 1200 mg of oral HCQ was considered safe and tolerated and inhibited tumor growth [167]. The same authors further assessed the HCQ anticancer properties and dose-limiting toxicity on 40 pati"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T210","span":{"begin":53,"end":61},"obj":"Phenotype"},{"id":"T211","span":{"begin":207,"end":212},"obj":"Phenotype"}],"attributes":[{"id":"A210","pred":"hp_id","subj":"T210","obj":"http://purl.obolibrary.org/obo/HP_0002861"},{"id":"A211","pred":"hp_id","subj":"T211","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"study on 27 patients with solid tumors and 12 with a melanoma diagnosis. In both cases, the standard intravenous dose of temsirolimus with 1200 mg of oral HCQ was considered safe and tolerated and inhibited tumor growth [167]. The same authors further assessed the HCQ anticancer properties and dose-limiting toxicity on 40 pati"}

{"project":"LitCovid-sentences","denotations":[{"id":"T542","span":{"begin":73,"end":226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"study on 27 patients with solid tumors and 12 with a melanoma diagnosis. In both cases, the standard intravenous dose of temsirolimus with 1200 mg of oral HCQ was considered safe and tolerated and inhibited tumor growth [167]. The same authors further assessed the HCQ anticancer properties and dose-limiting toxicity on 40 pati"}